Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Buprenorphine on Mood in Adults With Depressive Symptomatology
NCT02659787Completed
- Sponsor
- University of Chicago
- Start
- Jun 2016
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of buprenorphine in major depressive disorder (MDD) (2 arms), sponsored by University of Chicago. Primary endpoint: Drug Effects Questionnaire Subjective Response (Feel Drug, Feel High, Like Drug, Want More). Started Jun 2016; status: completed.
02
Drugs
buprenorphine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02659787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02659787.